CryoBio Secures $1.3 Million to Advance Frost Protection Technology for U.S. Farmers

What's Happening?

CryoBio, a New York-based company, has raised $1.3 million in a pre-seed funding round to develop its innovative frost protection technology for high-value crops like apples and grapes. The funding will be used to expand operations in New York and hire additional staff in biochemical engineering, biomanufacturing, and horticulture. CryoBio's technology is inspired by antifreeze proteins found in animals that survive in subzero temperatures. These proteins are produced by engineered microbes in a fermentation tank, extracted, and then supplied to farmers as a powder to be mixed with water and sprayed on crops before frost events. This approach aims to prevent the formation of large ice crystals that can damage crops. The company plans to conduct field trials in New York, Washington, and Canada, with a commercial launch expected in 2027.

Why It's Important?

The development of CryoBio's frost protection technology is significant for U.S. agriculture, as frost events can cause substantial crop losses, estimated at $854 million in 2024 alone. Traditional frost protection methods are often expensive and outdated, making CryoBio's solution a potentially cost-effective and efficient alternative. By reducing crop damage from frost, this technology could enhance the resilience and profitability of U.S. farmers, particularly those growing high-value crops. Additionally, the use of naturally occurring molecules may streamline regulatory approval, allowing for quicker adoption by farmers.

What's Next?

CryoBio is preparing for extensive field trials to validate its technology under real-world conditions. The company is also exploring the possibility of using different microbial hosts for large-scale production, which could reduce costs. As the technology progresses, CryoBio will seek state-level registration to expedite market entry. The company is also considering international markets, although regulatory pathways in regions like New Zealand, Australia, and Europe are still being explored. Successful trials and regulatory approvals could position CryoBio as a leader in agricultural biotechnology.